Tamarack Biotics obtains GRAS status for TruActive NF, further validating SurePure Technology Biotech Investing
Laguna signs a Canadian Exclusive Distribution Agreement with a Leading Distributor of CBD Products Biotech Investing
RepliCel Life Sciences Partners with European Firms to Develop Final Prototype of its Dermal Injector Medical Device Investing
Epizyme Announces 2016 Fourth Quarter and Full-Year Results Conference Call Date and March Investor Conferences Biotech Investing
Trillium Therapeutics Provides Additional Details on ASCO-SITC Conference Presentation on TTI-621 Biotech Investing
RepliCel Life Sciences Announces Closing of Brokered and Non-brokered Private Placement Biotech Investing
